Laser Interstitial Thermal Ablation & Stereotactic Radiosurgery for

Status Recruiting

Clinical Trial Summary

The purpose of this research is to combine two complementary modes of treatment, spinal interstitial laser ablation and stereotactic spine radiosurgery (SSRS) for the treatment for spinal tumors near the spinal cord with an objective to improve tumor control, improve pain control, preserve function, and improve quality of life. We will also assess how effective these combined modes of treatment are in patients with spinal metastasis with an epidural component.

Clinical Trial Description

Primary Objectives: 1. Documenting rate of local control in patients who have received this combined treatment and 2. Documenting safety of MRI compatible hardware for MRI based image guidance 3. Determining the accuracy of the MRI-based image guidance Secondary Objectives: 1. To determine local control at 1, 3, 6, 9, 18, and 24 months, and to compare to a historical control where patients received only SSRS at these time points and at 12 months. 2. To document the extent of epidural tumor regression at 1, 3, 6, 9, 12, 18 and 24 months - Calculate decrease in epidural tumor volume (by volumetric measurements using Brain Lab Elements software) - Calculate increase in thecal sac patency (by volumetric measurements using Brain Lab Elements software and according to Bilsky method 3. To determine overall survival at 6, 12, 18, and 24 months. 4. To assess changes in muscle strength, location and severity of spinal-related pain, sensory function, ability to ambulate, and neurological grading at 1, 3, 6, 9, 12, 18, and 24 months compared with pretreatment baselines. 5. To assess the effect of treatment on quality of life, measured at 1 month and every 3 months after with validated outcome measure tools 6. To describe adverse side effects after treatment and to descriptively correlate those effects with radiographic findings, pain control, and quality of life. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05023772
Study type	Interventional
Source	Henry Ford Health System
Contact	RAMONA DAVIS
Phone	3132821753
Email	RDavis18@hfhs.org
Status	Recruiting
Phase	N/A
Start date	September 2, 2021
Completion date	September 2025

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT06057636` - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study	N/A
Terminated	`NCT03166631` - A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread	Phase 1
Terminated	`NCT01441115` - ECI301 and Radiation for Advanced or Metastatic Cancer	Phase 1
Active, not recruiting	`NCT03775980` - CIRSE Emprint Microwave Ablation Registry
Completed	`NCT01114958` - Pilot Study of Intra-Arterial Cisplatin With IV Thiosulfate in Patients With Lung Cancer or Lung Metastases	Phase 1
Terminated	`NCT03986593` - Cryoablation of Bone Metastases From Endocrine Tumors	N/A
Active, not recruiting	`NCT04458259` - Study of PF-07265807 in Participants With Metastatic Solid Tumors.	Phase 1
Completed	`NCT01218542` - Whole Brain Radiation Therapy With Boost to Metastatic Tumor Volume Using RapidArc	N/A
Not yet recruiting	`NCT03175146` - A Study to See Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver Safely	N/A
Active, not recruiting	`NCT02395224` - A Longitudinal Study of Colorectal Cancer Patients With Metastatic Disease in Middle-Norway
Completed	`NCT02374411` - Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients	N/A
Recruiting	`NCT01960829` - Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study	Phase 2
Terminated	`NCT01846429` - Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain	Phase 1
Completed	`NCT01933789` - Improving Communication About Serious Illness	N/A
Recruiting	`NCT01564810` - Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer	Phase 4
Completed	`NCT00375245` - Rapamycin With Grapefruit Juice for Advanced Malignancies	Phase 1
Completed	`NCT00232726` - Clinical Study of Previously Untreated Patients With Malignant Melanoma	Phase 2
Completed	`NCT00207116` - An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Carcinoma	Phase 1
Completed	`NCT00207103` - MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors	Phase 1
Completed	`NCT00172003` - Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms